Gilead Sciences Announces First Quarter 2019 Financial Results

Go back to Gilead Sciences Announces First Quarter 2019 Financial Results

Gilead Sciences (GILD) Tops Q1 EPS by 15c, Reiterate Guidance

May 2, 2019 4:02 PM EDT

Gilead Sciences (NASDAQ: GILD) reported Q1 EPS of $1.76, $0.15 better than the analyst estimate of $1.61. Revenue for the quarter came in at $5.3 billion versus the consensus estimate of $5.3 billion.

Full Year 2019 Guidance... More